Marianna Caramella

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi et al. · Blood · 2009 · 968 citations · Full text

Medicine, Biostatistics, Oncology +14

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

Francesco Passamonti, Toni Giorgino, Barbara Mora et al. · Leukemia · 2017 · 334 citations · Full text

Medicine, Hematology, Molecular Medicine +5

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial

Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano et al. · The Lancet Haematology · 2021 · 132 citations · Full text

Medicine, Hematology, Pharmacotherapy +6

A dynamic prognostic model to predict survival in post–polycythemia vera myelofibrosis

Francesco Passamonti, Elisa Rumi, Marianna Caramella et al. · Blood · 2008 · 116 citations · Full text

Medicine, Biostatistics, Hematology +14